Imagen de Portada

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Xinran Huang, Jian Wang, Jing Ning
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Statistics in Medicine
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment
por: Daniel Backenroth, et al.
Publicado: (2026)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
por: Hyejung Jung, et al.
Publicado: (2026)

A Note on the Sample Size Formula for a Win Ratio Endpoint
por: Se Yoon Lee
Publicado: (2025)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
por: Gi‐Ming Wang, et al.
Publicado: (2026)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
por: Moka Komaki, et al.
Publicado: (2026)

A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien–Wei–Lachin
por: Guangyong Zou, et al.
Publicado: (2024)

Futility Monitoring in Clinical Trials
por: Ana M. Ortega‐Villa, et al.
Publicado: (2025)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
por: Jingya Gao, et al.
Publicado: (2024)

Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule
por: Juhee Lee, et al.
Publicado: (2024)

Two‐Stage Double‐Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical Region
por: Jiashan He, et al.
Publicado: (2026)

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine
por: Yuan Li, et al.
Publicado: (2025)

Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints
por: Huiman Barnhart, et al.
Publicado: (2025)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
por: Xiaotian Chen, et al.
Publicado: (2025)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
por: Alessandra Serra, et al.
Publicado: (2025)

Bayesian Power‐Based Sample Size Determination for Single‐Arm Clinical Trials With Time‐to‐Event Endpoints
por: Go Horiguchi, et al.
Publicado: (2026)

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
por: Jingyan Fu, et al.
Publicado: (2025)

A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design
por: Cyrus Mehta, et al.
Publicado: (2025)

Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints
por: Ryota Ishii, et al.
Publicado: (2025)

Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials
por: Jiaqi Tong, et al.
Publicado: (2025)

A Note on “A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design”
por: Silke Jörgens, et al.
Publicado: (2026)

BAR12 : Bayesian Autoregressive Phase 1‐2 Design for Cell Therapy Trials With Manufacturing Changes
por: Cheng‐Han Yang, et al.
Publicado: (2026)

Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
por: Shu Jiang, et al.
Publicado: (2025)

A Bayesian Two‐Step Multiple Imputation Approach Based on Mixed Models for Missing EMA Data
por: Yiheng Wei, et al.
Publicado: (2025)

Bayesian Random‐Effects Meta‐Analysis of Aggregate Data on Clinical Events
por: Christian Röver, et al.
Publicado: (2026)

A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
por: Yichen Yan, et al.
Publicado: (2025)

Nonparametric Path‐Specific Effects on a Survival Outcome Through Multiple Time‐to‐Event Mediators
por: Yen‐Tsung Huang, et al.
Publicado: (2025)

Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials
por: Marco Ratta, et al.
Publicado: (2026)

Semiparametric Inference for a Two‐Phase Failure‐Time‐Auxiliary‐Dependent Sampling Design
por: Xu Cao, et al.
Publicado: (2025)

A Partially Randomized Patient Preference, Sequential, Multiple‐Assignment, Randomized Trial Design Analyzed via Weighted and Replicated Frequentist and Bayesian Methods
por: Marianthie Wank, et al.
Publicado: (2024)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
por: Yuwei Cheng, et al.
Publicado: (2026)

Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology
por: Benjamin F. Hartley, et al.
Publicado: (2025)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
por: Adrien Ollier, et al.
Publicado: (2025)

Causal Rule Ensemble Approach for Multi‐Arm Data
por: Ke Wan, et al.
Publicado: (2026)

Accounting for Carryover Toxicity in Phase I Clinical Trials with Intra‐Patient Dose Escalation
por: Chloe E. Falke, et al.
Publicado: (2025)

Sequential Event Rate Monitoring
por: Dong‐Yun Kim, et al.
Publicado: (2026)

Time‐Varying Treatment Effect Models in Stepped‐Wedge Cluster‐Randomized Trials With Multiple Interventions
por: Zhe Chen, et al.
Publicado: (2026)

Bayesian Network Meta‐Analysis With One or Two Continuous Outcomes Measured at Multiple Time Points Using Gaussian Random Walks With Drift
por: Pai‐Shan Cheng, et al.
Publicado: (2026)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
por: David S. Robertson, et al.
Publicado: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
por: Liwen Wu, et al.
Publicado: (2025)

Time‐Dependent ROC Curve for Multiple Longitudinal Biomarkers and Its Application in Diagnosing Cardiovascular Events
por: Lizhe Sun, et al.
Publicado: (2025)